Aarti Pharmalabs Limited (AARTIPHARM.NS)
INR 679.4
(8.81%)
INR 679.4
(8.81%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.07 Billion INR | -38.01% |
| 2022 | 4.95 Billion INR | 631178.16% |
| 2021 | 785.66 Thousand INR | 1609.44% |
| 2020 | 45.96 Thousand INR | -75.39% |
| 2019 | 186.75 Thousand INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 910.45 Million INR | 11.63% |
| 2024 Q1 | 815.57 Million INR | -16.55% |
| 2023 Q4 | 977.3 Million INR | -23.26% |
| 2023 FY | 3.07 Billion INR | -38.01% |
| 2023 Q3 | 1.27 Billion INR | 8.21% |
| 2023 Q2 | 1.17 Billion INR | -1.73% |
| 2023 Q1 | 1.19 Billion INR | -61.28% |
| 2022 Q3 | -541.78 Million INR | -144.77% |
| 2022 FY | 4.95 Billion INR | 631178.16% |
| 2022 Q2 | 1.21 Billion INR | -60.88% |
| 2022 Q4 | 3.09 Billion INR | 670.9% |
| 2022 Q1 | 3.09 Billion INR | 106.43% |
| 2021 Q4 | 1.49 Billion INR | -0.0% |
| 2021 Q2 | 77.51 Thousand INR | 0.0% |
| 2021 Q3 | 1.49 Billion INR | 1932745.9% |
| 2021 FY | 785.66 Thousand INR | 1609.44% |
| 2021 Q1 | 77.51 Thousand INR | 0.0% |
| 2020 FY | 45.96 Thousand INR | -75.39% |
| 2019 FY | 186.75 Thousand INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 80.627% |
| Hester Biosciences Limited | 908.84 Million INR | -238.277% |
| Aarti Drugs Limited | 1.16 Billion INR | -163.337% |
| Albert David Limited | 1.02 Billion INR | -199.606% |
| Alembic Limited | 872.45 Million INR | -252.384% |
| Alkem Laboratories Limited | 32.83 Billion INR | 90.637% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -574.825% |
| Bajaj HealthCare Limited | 985.34 Million INR | -212.013% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -44979.179% |
| Brooks Laboratories Limited | 51.18 Million INR | -5907.034% |
| Eris Lifesciences Limited | 4.94 Billion INR | 37.802% |
| FDC Limited | 3.49 Billion INR | 12.154% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | 73.589% |
| Gufic Biosciences Limited | 1.18 Billion INR | -159.096% |
| Hikal Limited | 4.46 Billion INR | 31.126% |
| Ind-Swift Limited | 946.56 Million INR | -224.795% |
| Innova Captab Limited | 931.03 Million INR | -230.215% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -39.682% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -601.038% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 78.73% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -186.207% |
| Lupin Limited | 125.09 Billion INR | 97.542% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -1795.111% |
| Medico Remedies Limited | 59.67 Million INR | -5051.906% |
| Morepen Laboratories Limited | 1.98 Billion INR | -54.691% |
| Nectar Lifesciences Limited | 932.7 Million INR | -229.624% |
| Orchid Pharma Limited | 800.77 Million INR | -283.93% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -2.637% |
| RPG Life Sciences Limited | 1.63 Billion INR | -87.979% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -645.441% |
| Sigachi Industries Limited | 579.88 Million INR | -430.172% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -20.371% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -119.163% |
| Themis Medicare Limited | 1.12 Billion INR | -173.086% |
| Unichem Laboratories Limited | 6.72 Billion INR | 54.29% |
| Vaishali Pharma Limited | 84.02 Million INR | -3558.737% |
| Wanbury Limited | 978.96 Million INR | -214.046% |
| Windlas Biotech Limited | 1 Billion INR | -205.452% |
| ZIM Laboratories Limited | 1.01 Billion INR | -203.477% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -44.733% |
| Ipca Laboratories Limited | 18.98 Billion INR | 83.808% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 98.006% |
| Venus Remedies Limited | 1.91 Billion INR | -60.436% |
| Sakar Healthcare Limited | 204.07 Million INR | -1406.475% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 94.476% |
| Divi's Laboratories Limited | 14.17 Billion INR | 78.303% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -24.294% |
| Mankind Pharma Limited | 29.27 Billion INR | 89.497% |
| Sequent Scientific Limited | 2.9 Billion INR | -5.948% |
| Laurus Labs Limited | 11.9 Billion INR | 74.186% |
| Neuland Laboratories Limited | 2.92 Billion INR | -4.937% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 79.217% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 93.452% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 97.545% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -46.817% |
| Wockhardt Limited | 8.48 Billion INR | 63.745% |
| Bal Pharma Limited | 555.62 Million INR | -453.322% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 96.793% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -116.626% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -5174.497% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -41.384% |
| Shilpa Medicare Limited | 3.33 Billion INR | 7.791% |
| Valiant Laboratories Limited | 138.02 Million INR | -2127.358% |
| Ajanta Pharma Limited | 30.46 Billion INR | 89.908% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -21530.901% |
| Granules India Limited | 10.31 Billion INR | 70.189% |
| Medicamen Biotech Limited | 335.16 Million INR | -817.274% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -789.498% |
| Piramal Enterprises Limited | 63.65 Billion INR | 95.17% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 85.648% |
| NATCO Pharma Limited | 10.05 Billion INR | 69.433% |
| Suven Life Sciences Limited | 109.75 Million INR | -2701.276% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -6560.889% |
| Strides Pharma Science Limited | 9.16 Billion INR | 66.445% |
| Indoco Remedies Limited | 12.06 Billion INR | 74.51% |
| Alpa Laboratories Limited | 127.38 Million INR | -2313.566% |
| Lasa Supergenerics Limited | 291.17 Million INR | -955.864% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 0.078% |